Search research articles
Contact Us
Filters
Showing results (111-120 of 140) with videos related to
Page
of 14
Sort By:
Journal of Geriatric Oncology
|
November 24, 2017
The effect of adjuvant chemotherapy on symptom burden and quality of life over time; a preliminary prospective observational study using individual data of patients aged ≥70 with early stage invasive breast cancer
Chantal Quinten, C Kenis, M Hamaker, et al.
Breast Cancer Research and Treatment
|
December 1, 2010
Prediction of lymph node involvement in breast cancer from primary tumor tissue using gene expression profiling and miRNAs
A Smeets, A Daemen, I Vanden Bempt, et al.
Ultrasound in Obstetrics & Gynecology : the Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology
|
March 11, 2010
Prospective external validation of the 'ovarian crescent sign' as a single ultrasound parameter to distinguish between benign and malignant adnexal pathology
C Van Holsbeke, V Van Belle, F P G Leone, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 11, 2012
Zoledronic acid (zoledronate) for postmenopausal women with early breast cancer receiving adjuvant letrozole (ZO-FAST study): final 60-month results
R Coleman, R de Boer, H Eidtmann, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 12, 2012
Applying the 2011 St Gallen panel of prognostic markers on a large single hospital cohort of consecutively treated primary operable breast cancers
O Brouckaert, A Laenen, J Vanderhaegen, et al.
ESMO Open
|
January 20, 2026
Exploring the treatment gap and outcome risks in patients with node-positive, high-risk, HR-positive, HER2-negative early breast cancer: analyses of real-world data
S M Tolaney, S Sammons, A Sandoval-Leon, et al.
ESMO Open
|
January 9, 2026
A phase IV prospective study of efficacy and safety of ribociclib and letrozole as first-line therapy in older women (≥70 years) with hormone receptor-positive HER2-negative advanced breast cancer: the RibOB study
M Van Houdt, C Kenis, L De Nys, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 1, 2011
Stellate ganglion block for the management of hot flashes and sleep disturbances in breast cancer survivors: an uncontrolled experimental study with 24 weeks of follow-up
K Haest, A Kumar, B Van Calster, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 1, 2016
Safety of everolimus plus exemestane in patients with hormone-receptor-positive, HER2-negative locally advanced or metastatic breast cancer progressing on prior non-steroidal aromatase inhibitors: primary results of a phase IIIb, open-label, single-arm, expanded-access multicenter trial (BALLET)
G Jerusalem, G Mariani, E M Ciruelos, et al.
Journal of Cancer Research and Clinical Oncology
|
January 20, 2021
Features of durable response and treatment efficacy for capecitabine monotherapy in advanced breast cancer: real-world evidence from a large single-centre cohort
S Thijssen, H Wildiers, K Punie, et al.
Page
of 14
Search research articles
Search
Showing results (111-120 of 140) with videos related to
Sort By:
Page
of 14
Journal of Geriatric Oncology
|
November 24, 2017
The effect of adjuvant chemotherapy on symptom burden and quality of life over time; a preliminary prospective observational study using individual data of patients aged ≥70 with early stage invasive breast cancer
Chantal Quinten, C Kenis, M Hamaker, et al.
Breast Cancer Research and Treatment
|
December 1, 2010
Prediction of lymph node involvement in breast cancer from primary tumor tissue using gene expression profiling and miRNAs
A Smeets, A Daemen, I Vanden Bempt, et al.
Ultrasound in Obstetrics & Gynecology : the Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology
|
March 11, 2010
Prospective external validation of the 'ovarian crescent sign' as a single ultrasound parameter to distinguish between benign and malignant adnexal pathology
C Van Holsbeke, V Van Belle, F P G Leone, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 11, 2012
Zoledronic acid (zoledronate) for postmenopausal women with early breast cancer receiving adjuvant letrozole (ZO-FAST study): final 60-month results
R Coleman, R de Boer, H Eidtmann, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 12, 2012
Applying the 2011 St Gallen panel of prognostic markers on a large single hospital cohort of consecutively treated primary operable breast cancers
O Brouckaert, A Laenen, J Vanderhaegen, et al.
ESMO Open
|
January 20, 2026
Exploring the treatment gap and outcome risks in patients with node-positive, high-risk, HR-positive, HER2-negative early breast cancer: analyses of real-world data
S M Tolaney, S Sammons, A Sandoval-Leon, et al.
ESMO Open
|
January 9, 2026
A phase IV prospective study of efficacy and safety of ribociclib and letrozole as first-line therapy in older women (≥70 years) with hormone receptor-positive HER2-negative advanced breast cancer: the RibOB study
M Van Houdt, C Kenis, L De Nys, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 1, 2011
Stellate ganglion block for the management of hot flashes and sleep disturbances in breast cancer survivors: an uncontrolled experimental study with 24 weeks of follow-up
K Haest, A Kumar, B Van Calster, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 1, 2016
Safety of everolimus plus exemestane in patients with hormone-receptor-positive, HER2-negative locally advanced or metastatic breast cancer progressing on prior non-steroidal aromatase inhibitors: primary results of a phase IIIb, open-label, single-arm, expanded-access multicenter trial (BALLET)
G Jerusalem, G Mariani, E M Ciruelos, et al.
Journal of Cancer Research and Clinical Oncology
|
January 20, 2021
Features of durable response and treatment efficacy for capecitabine monotherapy in advanced breast cancer: real-world evidence from a large single-centre cohort
S Thijssen, H Wildiers, K Punie, et al.
Page
of 14